Reaction

Oligohydramnios reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 3,308 reports · 89 co-occurring drugs

As of the last recalculation, Oligohydramnios appears in 3,308 FAERS reports alongside 89 co-occurring drug terms. The strongest observed disproportionality signal is INDOMETHACIN (PRR 56.5).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Indomethacin	115	56.5	57.0
Valsartan Oral	251	31.4	31.5
Labetalol	62	29.8	29.9
Misoprostol	36	23.5	23.6
Nevirapine	28	19.7	19.7
Ifosfamide	61	18.2	18.2
Candesartan Cilexetil	73	17.8	17.9
Valsartan	270	17.5	17.6
Progesterone	57	15.9	16.0
Dolutegravir Sodium	21	14.7	14.8
Trastuzumab	153	14.7	14.7
Erythromycin	43	14.6	14.6
Ampicillin	18	13.7	13.8
Ampicillin Sodium	18	13.7	13.8
Atazanavir	31	13.7	13.7
Nicotine Polacrilex Mini	32	13.5	13.6
Nicotine Polarilex	32	13.5	13.6
Zidovudine	27	12.8	12.8
Lopinavir And Ritonavir	27	12.6	12.7
Olmesartan Medoxomil	70	12.5	12.5
Tenofovir Disoproxil Fumarate Tablets	17	12.4	12.5
Bleomycin Sulfate	19	11.6	11.7
Diclofenac	148	11.3	11.3
Amitriptyline Hydrochloride	31	11.2	11.2
Darunavir	26	10.9	10.9
Candesartan	58	10.4	10.4
Nifedipine	76	10.3	10.4
Phytonadione	13	9.7	9.7
Benralizumab	30	9.5	9.5
Pyrazinamide	14	9.4	9.4
Ritonavir	43	9.4	9.4
Ibuprofen Capsule	268	9.1	9.1
Ibuprofen Tablet, Film Coated	268	9.1	9.1
Ibupfrofen	268	9.1	9.1
Ibuprofen Tablets Usp, 200Mg	268	9.1	9.1
Ibuprofen Oral	268	9.1	9.1
Ibuprofen Capsules 200 Mg	268	9.1	9.1
Ibuprofen 200 Mg	268	9.1	9.1
Ibuprofen 200Mg	268	9.1	9.1
Captopril	13	8.5	8.5
Goserelin	18	8.5	8.5
Drs. Clotrimazole	15	8.2	8.2
Family Wellness Clotrimazole	15	8.2	8.2
Clotrimazole Topical	15	8.2	8.2
Clotrimazole	15	7.7	7.7
Pertuzumab	33	7.7	7.7
Diclofenac Sodium	161	7.0	7.0
Ibuprofen	281	7.0	7.0
Doxorubicin	94	6.8	6.8
Lamivudine	31	6.4	6.4
Paclitaxel (Aibumin-Bound)	77	6.0	6.0
Telmisartan	16	5.7	5.7
Nicotine Polacrilex	34	5.6	5.6
Lamivudine Oral	22	5.5	5.5
Dalteparin Sodium	9	5.4	5.4
Magnesium Sulfate Heptahydrate	11	5.3	5.3
Insulin Glargine-Yfgn	18	5.2	5.2
Nicotine	33	5.2	5.2
Diclofenac Sodium 1%	29	5.1	5.1
Diclofenac Sodium Topical	29	5.1	5.1
Diclofenac Sodium Topical Gel, 1%	29	5.1	5.1
Isoniazid	13	5.1	5.1
Insulin	44	5.0	5.0
Paclitaxel	77	5.0	5.0
Magnesium Sulfate In Water For	10	4.9	4.9
Magnesium Sulfate	10	4.8	4.8
Tenofovir Disoproxil Fumarate	25	4.8	4.8
Rifampin	11	4.8	4.8
Doxorubicin Hydrochloride	24	4.7	4.7
Mesna Injection	6	4.6	4.6
Mesna	6	4.5	4.5
Cyclophosphamide Injection, Solution	120	4.4	4.4
Cyclophosphamide	120	4.4	4.4
Cyclophosphamide For Injection	120	4.4	4.4
Anakinra	11	4.2	4.2
Emtricitabine And Tenofovir Disoproxil Fumarate	30	4.2	4.2
Losartan Potassium	51	4.1	4.1
Amlodipine Besylate And Valsartan	7	4.0	4.0
Sumatriptan Succinate	15	3.7	3.7
Losartan	100	3.7	3.7
Naproxen Sodium Tablet, Coated	7	3.3	3.3
Naproxen Sodium, Coated Tablets	7	3.3	3.3
Naproxen Sodium 220Mg	7	3.3	3.3
Buprenorphine Hydrochloride, Naloxone Hydrochloride	12	3.1	3.1
Etoposide	31	2.7	2.7
Erlotinib	4	2.6	2.6
Eptinezumab-Jjmr	3	2.1	2.1
Orlistat	8	1.9	1.9
Levonorgestrel	28	0.9	0.9

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.